Various aspects of motor fluctuations and their management in Parkinson's disease
- PMID: 8047258
Various aspects of motor fluctuations and their management in Parkinson's disease
Abstract
Major motor fluctuations in patients with Parkinson's disease during levodopa treatment include "wearing-off" fluctuations, "on-off" fluctuations, freezing, and early morning dystonia. Other fluctuations, such as drug resistant "off periods," complicated "end-of-dose" effects and "resistant fluctuators" can also occur. In this paper, the underlying pathophysiologic mechanisms of the major motor fluctuations are reviewed, and practical approaches to manage these problems are discussed. "Wearing-off" fluctuations are most common, and several different mechanisms appear to be operating, including the interference of food in the gastrointestinal absorption of levodopa, inhibition of transport of levodopa to the brain by large neutral amino acids or 3-O-methyldopa, and progression of the degeneration of dopaminergic nerve terminals. The mechanisms of "on-off" fluctuations and freezing are not well understood. Loss of cerebral noradrenaline that results from locus coeruleus degeneration may, in part, be responsible for freezing. To minimize the occurrence of these motor fluctuations, multiple classes of antiparkinsonian drugs need to be used, so that the dose of levodopa can be maintained at a reasonably low level.
Similar articles
-
Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.Brain. 2004 Apr;127(Pt 4):888-99. doi: 10.1093/brain/awh102. Epub 2004 Feb 11. Brain. 2004. PMID: 14960500
-
Clinical aspects of motor fluctuations in Parkinson's disease.Neurology. 1994 Jul;44(7 Suppl 6):S6-9. Neurology. 1994. PMID: 8047260 Review.
-
Motor complications associated with chronic levodopa therapy in Parkinson's disease.Neurology. 1989 Nov;39(11 Suppl 2):11-9. Neurology. 1989. PMID: 2685647 Review.
-
Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.Ann Neurol. 1988 Sep;24(3):372-8. doi: 10.1002/ana.410240304. Ann Neurol. 1988. PMID: 3228271
-
Treating motor fluctuations with controlled-release levodopa preparations.Neurology. 1994 Jul;44(7 Suppl 6):S23-8. Neurology. 1994. PMID: 8047257 Review.
Cited by
-
Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease.J Neurol Neurosurg Psychiatry. 2007 May;78(5):470-5. doi: 10.1136/jnnp.2006.100016. Epub 2006 Nov 10. J Neurol Neurosurg Psychiatry. 2007. PMID: 17098845 Free PMC article. Clinical Trial.
-
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.Neurology. 2011 Apr 5;76(14):1256-62. doi: 10.1212/WNL.0b013e3182143537. Neurology. 2011. PMID: 21464430 Free PMC article. Clinical Trial.
-
Noradrenergic modulation of subthalamic nucleus activity: behavioral and electrophysiological evidence in intact and 6-hydroxydopamine-lesioned rats.J Neurosci. 2007 Sep 5;27(36):9595-606. doi: 10.1523/JNEUROSCI.2583-07.2007. J Neurosci. 2007. PMID: 17804620 Free PMC article.
-
Noradrenaline and Parkinson's disease.Front Syst Neurosci. 2011 May 18;5:31. doi: 10.3389/fnsys.2011.00031. eCollection 2011. Front Syst Neurosci. 2011. PMID: 21647359 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical